Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating encouraging results in the management of type 2 diabetes. This artificial peptide duplicates the actions of naturally present GLP-1, a https://bookmarkbells.com/story20888201/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes